The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Evotec and Jain Foundation Expand Research Collaboration (2014-09-15)
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and the Jain Foundation Inc. today announced that they have further extended and expanded the collaboration first signed in 2012 and extended last year. This next phase of collaboration includ...
- Affimed Prices US IPO of $56m, with $8.4m Greenshoe (2014-09-12)
Affimed Therapeutics today announced the pricing of its initial public offering of 8,000,000 common shares at an initial public offering price of $7.00 per common share. In addition, Affimed has granted the underwriters a 30-day option to purchase up to an addition...
- Biocartis Launches Its Molecular Diagnostics Platform Idylla (2014-09-12)
> With the launch of Idylla™, Biocartis aims to set a new golden standard in molecular diagnostics. > Idylla™'s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidanc...
- Merck Serono Discontinues Tecemotide in Phase 3 NSCLC Study (2014-09-12)
Merck announced today that its biopharmaceutical division Merck Serono will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) as a monotherapy in Stage III non-small cel...
- Waters Unveils Global Mass Spec Headquarters in Wilmslow, UK (2014-09-11)
The Right Honourable George Osborne MP joins Waters CEO Doug Berthiaume to mark the official opening of the Waters Mass Spectrometry Headquarters in Wilmslow Waters Corporation (NYSE: WAT) today celebrated the official opening of its new, custom-built mass spe...
- Mologen Starts Phase 3 with MGN1703 in Colorectal Cancer (2014-09-11)
> First patient enrolled > Pivotal study to evaluate overall survival MOLOGEN AG has enrolled the first patient in the international IMPALA study. Primary objective of the phase III pivotal trial is to prove that a switch maintenance therapy with the cancer...
- Alizé Pharma Raises €5m from bpifrance and Others (2014-09-10)
The proceeds will finance the clinical development program of AZP-531 (an unacylated ghrelin analog) in Prader-Willi syndrome and type 2 diabetes Bpifrance led the financing campaign via the InnoBio fund Alizé Pharma SAS, an Alizé Pharma group company speci...
- Poxel Raise €10m to Progress Two Type 2 Diabetes Drugs (2014-09-09)
Poxel SA announces today, that it has raised EUR10 million ($13.5 million) through a Series B extension with the Large Venture investment division of Bpifrance (Banque Publique d'Investissement) and a debt facility from Kreos Capital. The Series B financing, origin...
- ProBioGen to Invest €20m in Manufacturing Expansion (2014-09-09)
On the occasion of its 20th anniversary, ProBioGen AG announced to invest 20€ million and to double its workforce. CEO Dr. Wieland Wolf welcomed scientific, business and political guests in a ceremony in Berlin on September 4, 2014. On behalf of pharmaceutical a...
- Angle plc Announces Collaboration with UKE (2014-09-08)
ANGLE plc (AIM: AGL), the specialist medtech company, is pleased to announce it has signed a collaboration agreement with The University Medical Center Hamburg-Eppendorf (UKE), a world leader in circulating tumour cell (CTC) research and part of the University Canc...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSe] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)